Advances in Anti-Rheumatic Therapy
CRC Press (Verlag)
978-0-367-24689-1 (ISBN)
K.D. Rainsford is Professor and Head, Division of Biomedical Sciences, School of Science, Sheffield Hallam University, Sheffield, England.
1. Introduction to Advances in Anti-Rheumatic Therapy 2. Outcome Measures in Clinical Trials of Anti-Rheumatic Drugs 3. The Elderly as the Main Group for Therapy with Anti-Rheumatic Drugs – Problems and Strategies 4. Changing Views on the Approach to Rehabilitation and Outcome Evaluation in Rheumatoid Arthritis, in the Light of Recent Advances in Cognitive Psychology 5. Mode of Action, Uses, and Side Effects of Anti-Inflammatory Drugs 6. Clinical Development of an NSAID Combined with a Prostaglandin E, Analogue 7. Azapropazone (AZP): New Therapeutic Indications for an Established Drug, Demonstration of Antineutrophil Effects in Various Animal Models and in Humans 8. Recent Advances in the Understanding of the Mode of Action of Glucorticoids 9. The Rheumaoid Arthritis Registry – An Update 10. Subreum ® (OM-8980) and Rheumatoid Arthritis – A Novel Immunomodulating Drug from Natural Product Development 11. Clinical Trials of Oral Chrondroitin Suplhate in the Treatment of Osteoarthritis 12. Zileuon (ABT-077) A Novel 5-Lipoxygenase Inhibitor 13. Selective Monoclonal Antibodies for Therapy of Rheumatic Diseases 14. Dietary Polyunsaturdated Fatty Acids as Natural Therapeutic Rationales
| Erscheinungsdatum | 04.02.2022 |
|---|---|
| Reihe/Serie | Routledge Revivals |
| Co-Autor | Richard A. Watts, Shaker A. Mousa, Joel M. Kremer, W. Watson Buchanan |
| Zusatzinfo | 54 Tables, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie | |
| ISBN-10 | 0-367-24689-9 / 0367246899 |
| ISBN-13 | 978-0-367-24689-1 / 9780367246891 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
